Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00942513
Other study ID # 2007-342
Secondary ID
Status Completed
Phase N/A
First received July 17, 2009
Last updated February 8, 2011

Study information

Verified date February 2011
Source USDA Beltsville Human Nutrition Research Center
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Does the consumption of various combinations of mono and disaccharides (lactose, sucrose and fructose) and protein isolates (whey or soy) result in altered substrate absorption, substrate oxidation, and glucose regulation? This proposed research will provide data to determine the relative contribution of source of protein (whey vs soy) and carbohydrate (mono- and disaccharides) on the observed effects of dairy products on absorption, substrate oxidation and glucoregulation mechanisms that affect body composition.


Description:

Epidemiological research has shown that dairy products aid in weight loss and weight maintenance. Some evidence suggests that this effect is due to the whey component (which contains whey proteins and lactose) of milk. Previous work from our laboratory has demonstrated that chronic administration of whey protein concentrate results in decreased body fat and insulin concentration. Recent research (unpublished) from Castonguay and colleagues (University of Maryland, College Park, MD) has suggested that specific combinations of sucrose, maltose and lactose similarly alter body fat levels in rats. This proposed research will provide data to determine the relative contribution of source of protein (whey vs soy) and carbohydrate (mono- and disaccharides) on the observed effects of dairy products on absorption, substrate oxidation and glucoregulation mechanisms that affect body composition.


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria:

- Male.

- BMI at least 20 and less than 38 kg/m2 and body weight < 300 lbs.

- Age 25 to 65 years at beginning of study.

- Fasting glucose < 126 mg/dL.

- Blood pressure < 160/100 mm Hg.

- Total plasma cholesterol < 280 mg/dL.

- Nonsmokers or tobacco users (for at least 6 months prior to the start of the study.)

Exclusion Criteria:

- History or presence of kidney disease, liver disease, gout, certain cancers, thyroid disease, gastrointestinal, other metabolic diseases, or malabsorption syndromes.

- Type 2 diabetes requiring the use of oral antidiabetic agents or insulin.

- History of eating disorders.

- Volunteers who routinely participate in heavy exercise or volunteers who initiate an exercise program during the study.

- Volunteers who have lost 10% of body weight within the last 12 months .

- Volunteers who have been on Atkins, South Beach or similar diet in 3 months prior to start of study.

- Use of prescription or over-the-counter antiobesity medications or supplements (e.g., phenylpropanalamine, ephedrine, caffeine, during and for at least 6 months prior to the start of the study).

- Known (self-reported) allergy or adverse reaction to dairy products (including lactose) or soy.

- Volunteers who consume whey or soy protein supplements.

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)


Intervention

Other:
trt 1
Fructose - 14 g; Lactose - 10 g; Sucrose - 16 g; Starch - 40 g; Whey Protein Isolate - 40 g; Soy Protein Isolate - 0 g
trt 2
Fructose - 30 g; Lactose - 10 g; Sucrose - 0 g; Starch - 40 g; Whey Protein Isolate - 40 g; Soy Protein Isolate - 0 g
trt 3
Fructose - 24 g; Lactose - 8 g; Sucrose - 8 g; Starch - 40 g; Whey Protein Isolate - 40 g; Soy Protein Isolate - 0 g
trt 4
Fructose - 0 g; Lactose - 0 g; Sucrose - 40 g; Starch - 40 g; Whey Protein Isolate - 40 g; Soy Protein Isolate - 0 g
trt 5
Fructose - 0 g; Lactose - 0 g; Sucrose - 40 g; Starch - 40 g; Whey Protein Isolate - 0 g; Soy Protein Isolate -40 g
trt 6
Fructose - 0 g; Lactose - 40 g; Sucrose - 0 g; Starch - 40 g; Whey Protein Isolate - 40 g; Soy Protein Isolate - 0 g
trt 7
Fructose - 0 g; Lactose - 40 g; Sucrose - 0 g; Starch - 40 g; Whey Protein Isolate - 0 g; Soy Protein Isolate -40 g

Locations

Country Name City State
United States USDA-ARS, Beltsville Human Nutrition Research Center Beltsville Maryland

Sponsors (1)

Lead Sponsor Collaborator
United States Department of Agriculture (USDA)

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT04818905 - Helichrysum Italicum Infusion Ingestion in Humans N/A
Recruiting NCT06308731 - Exercise-Induced Rates of Fat Oxidation With and Without Ingestion of a Caffeine-Based Energy Drink N/A
Completed NCT01888991 - Substrate Oxidation Does Not Affect Short Term Food Intake in Healthy Boys and Men N/A
Completed NCT03721874 - Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation Phase 4